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A SUBSTANTIAL NUMBER of experiments
have shown that chemical and radiation
carcinogenesis can be inhibited by various
agents (Wattenberg et al., 1977). Nomura
1976, 1978, 1980) found that after-treat-
mentwith caffeinesuppressedlung tumori-
genesis induced in mice by either 4 nitro-
quinoline-l-oxide (4NQO) or urethane,
supporting the hypothesis ofKondo (1971,
1977) that caffeine may suppress 4NQO-
induced carcinogenesis in mice in a similar
way to the diminution of 4NQO-induced
mutagenesis in Escherichia coli by in-
hibition ofmisrepair in DNA. Ifthis hypo-
thesis is applied to other antimutagens,
antipain [(l-carboxy-2-phenylethyl) car-
bamoyl-L-arginyl-L-valyl-arginal] (Fig. 1)
may also inhibit chemical carcinogenesis,
since antipain has been reported to be
antimutagenic to mutagenesis in E. coli by
UV (Meyn et al., 1977) and by 4NQO
(Ichikawa-Ryo & Kondo, 1980). This
paper deals with the effects of after-treat-
ment with antipain on lung neoplasia in-
duced by urethane in mice.
Young adult female ICR/Jcl mice (25
days old and weighing 14-16 g) (Nomura,
1974) were given a single s.c. injection of
urethane (ethyl carbamate, 1-0 mg/g body
wt) and then subjected to 11 i.p. injec-
tions of antipain (100 ,g/g body wt for
each) at 12h intervals from 0 to 120 h or
240 to 360 h after urethane treatment. A
control group received an equal volume of
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distilled water during the period 0-120 h
after urethane treatment. Urethane (Wako
Pure Chemical Ind. Ltd, Osaka, Japan)
and antipain (obtained underthe Research
Resources Programme forCancerResearch
of the Japanese Ministry of Education,
Science and Culture) were dissolved in
distilled water to the concentration of
10% and 1% respectively. Both chemicals
were prepared just before use. The dose of
antipain was close to a maximum tolerated
dose for 25-day-old ICR/Jcl mice, and
was given at 12h intervals for 5 days in
order to maintain a nearly equal level of
antipain in the tissue during the after-
treatment period. The treatment with
antipain neither increased mortality nor
decreased the body wt of the mice pre-
treated with urethane (data not shown).
Mice were maintained on the mouse diet
CA-1 (Nomura, 1974) and tap water in a
conventional mouse room at 23-25°C, and
killed at 5 months after urethane treat-
ment. Gross pathological lesions, especi-
ally lung tumours, were examined as
describedpreviously (Nomura & Okamoto,
1972). The specimens were examined
microscopically after staining with
haematoxylin and eosin. Most lung
tumours were papillary adenomas. Lung-
tumour frequencies, defined as the average
numbers oftumour nodules per lung, were
compared statistically among the experi-
mental groups, since the frequency thus
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FIG. Chemical structure of antipain (Matsushima et al., 1976)
TABLE I.-Inhibitory effect of antipain on carcinogenesis in mice initiated with 1 mg/g
urethane
Antipain
(Gtg/g)
0
100
100
Hours of
antipain ,-
treatment
after
urethane
treatment Incidence
0-120 49/53
0-120 38/46
240-360 34/45
Lung tumours
92-5
82-6
75-6
Tumours/
lung
(mean
p* +s.e.)
12-3+1-3
NS 7-2+1-2
<0 05 7-4+1-4
* X2 test with Yates's correction for Groups 2 and 3 against 1.
t t test for Groups 2 and 3 against 1.
I OC, ovarian cystadenoma; L, lymphocytic leukaemia.
defined increases with dose of carcinogens
even in the high dose range in which the
fraction of tumour-bearing mice in sur-
vivors levels off (Nomura, 1978).
Table I summarizes the results. The
lung tumour yields induced by urethane
were significantly reduced by after-treat-
ment with antipain. The extent of inhibi-
tion was about 40% whether the antipain
was given for 5 days immediately or 10
days after urethane treatment. The long
antipain-sensitive period for tumour sup-
pression will not, however, invalidate the
hypothesis that antipain may inhibit the
initial process of lung tumorigenesis by
inhibiting misrepair of urethane-induced
DNA damage, because the pattern of the
antineoplastic action of antipain is similar
to that of caffeine (Table II). Nomura
(1976, 1978, 1980) has reported that
caffeine acts on the cells carrying DNA
damage only when these cells start the
first DNA replication after the carcinogen
treatment. This could be one reason why
urethane-treated mice remain sensitive
for at least 10 days to the antineoplastic
action of caffein or antipain, since the
generation time of the target cells in the
mouse lung (Type 2 cells) responsible for
neoplastic conversion is about 20-25 days
in the young adult. During the prepara-
tion of this paper, however, K.uroki &
Drevon (1979) reported that mutations in
cultured hamster cells induced by UV and
TABLE II.-Comparison of the antineo-
plastic action of antipain and caffeine.
Maximum tolerated doses ofantipain and
caffeine (100 ,ug/gfor each) were givenfor
5 days after a single s.c. injection of
urethane (1 mg/g). Details of caffeine
experiments were reported previously
(Nomura, 1978, 1980) and thosefor anti-
pain are given in the text
After
treatment
Water
Antipain
Caffeine
Antipain
Caffeine
Duration
(h)
0-120
0-120
0-120
240-360
240-360
Relative
tumour
frequency*
1-0
0 59
0-43
0-60
053
* Ratio of average number of tumours per lung in
the treated groups to those in the control group.
Group
1
2
3
Pt
< 0 005
<0-01
Other:
tumours
1 OC, 4L
1 OC, 4L
IL
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some chemical carcinogens cannot be re-
duced by antipain, in contrast to muta-
genesis in E. coli (Meyn et al., 1977;
Ichikawa-Ryo & Kondo, 1980). Further,
they reported that transformation induced
by 3-methylcholanthrene (MCA) is dimin-
ished only when antipain is applied for the
very long period of 4 weeks, starting 1
week after MCA treatment. Consequently,
it is uncertain whether antipain suppresses
urethane-induced tumorigenesis by its
inhibiting action on misrepair ofurethane-
induced DNA damage. It may block the
promotion of the preneoplastic state of
cells initiated by urethane, as the protease
inhibitors leupeptinandtosyllysine chloro-
methyl ketone inhibit the promotion of
cancer in the mouse skin after 7,12-
dimethylbenz(a)anthracene (Troll et al.,
1970; Hozumi et al., 1972) even though
leupeptin does not seem to inhibit
urethane-induced lung tumours (Matsu-
shima et al., 1976).
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